ArcticZymes Technologies ASA (OSL:AZT)
20.10
-0.60 (-2.90%)
Jun 25, 2026, 11:29 AM CET
OSL:AZT Revenue
ArcticZymes Technologies ASA had revenue of 35.05M NOK in the quarter ending March 31, 2026, with 40.86% growth. This brings the company's revenue in the last twelve months to 128.37M, up 24.66% year-over-year. In the year 2025, ArcticZymes Technologies ASA had annual revenue of 118.21M with 9.34% growth.
Revenue (ttm)
128.37M
Revenue Growth
+24.66%
P/S Ratio
8.24
Revenue / Employee
2.52M
Employees
51
Market Cap
1.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 118.21M | 10.10M | 9.34% |
| Dec 31, 2024 | 108.11M | -11.54M | -9.65% |
| Dec 31, 2023 | 119.65M | -18.02M | -13.09% |
| Dec 31, 2022 | 137.67M | 6.62M | 5.05% |
| Dec 31, 2021 | 131.05M | 33.23M | 33.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 16.27M |
| Aqua Bio Technology ASA | 7.53M |
| Nykode Therapeutics AS | 5.42M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
| Circio Holding ASA | 123.00K |
ArcticZymes Technologies ASA News
- 7 weeks ago - ArcticZymes Technologies ASA Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - ArcticZymes Technologies ASA Slides: Q1 2026 - Filings
- 7 weeks ago - ArcticZymes Technologies ASA Quarterly report: Q1 2026 - Filings
- 3 months ago - ArcticZymes Technologies ASA Transcript: CMD 2026 - Transcripts
- 3 months ago - ArcticZymes Technologies ASA Press release: FY 2026 - Filings
- 3 months ago - ArcticZymes Technologies ASA Slides: FY 2026 - Filings
- 4 months ago - ArcticZymes Technologies ASA Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - ArcticZymes Technologies ASA Quarterly report: Q4 2025 - Filings